Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy-Reference-Cited by-同舟云学术

Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy

Published:2006-04-04 Issue:6 Volume:20 Page:863-870
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Matthews Gail V,Bartholomeusz Angeline,Locarnini Stephen,Ayres Anna,Sasaduesz Joe,Seaberg Eric,Cooper David A,Lewin Sharon,Dore Gregory J,Thio Chloe L

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference35 articles.

1. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value;Ockenga;J Hepatol,1997

2. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects;Kellerman;J Infect Dis,2003

3. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral treatment;Lincoln;HIV Med,2003

4. Seroprevalence and coprevalence of HIV and HBsAg in Nigerian children with/without protein energy malnutrition;Akenami;Acta Trop,1997

5. The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state;Bodsworth;J Infect Dis,1991

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Antiretroviral Therapies in Pregnant Women Living With Human Immunodeficiency Virus and Hepatitis B Virus;Obstetrics & Gynecology;2023-08-03

2. High frequency of Lamivudine and Telbivudine resistance mutations in hepatitis B virus isolates from human immunodeficiency virus co-infected patients on highly active antiretroviral therapy in Bucaramanga, Colombia;Frontiers in Microbiology;2023-07-24

3. A review on the epidemiology of HBV and HIV co-infection;CHRISMED Journal of Health and Research;2023

4. HIV: hepatic manifestations of HIV and antiretroviral therapy;Comprehensive Guide to Hepatitis Advances;2023

5. Virological responses to tenofovir-alafenamide-containing antiretroviral therapy in people living with HIV co-infected with lamivudine-resistant or lamivudine-susceptible hepatitis B virus;International Journal of Antimicrobial Agents;2022-11